Research graph
References from Comparative associations of cumulative cholesterol-HDL-glucose index and triglyceride-glucose index with risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study. Local targets link to admitted publications; unresolved targets remain external evidence.
Cardiovascular-kidney-metabolic health: A presidential advisory from the American Heart Association
10.1161/cir.0000000000001184 · 2023 · External reference
A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: A scientific statement from the American Heart Association
10.1161/cir.0000000000001186 · 2023 · External reference
Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan
10.1111/dom.14829 · 2022 · External reference
Association of cardiovascular-kidney-metabolic syndrome with cognitive decline and dementia: The ARIC study insights
10.1161/jaha.124.038445 · 2025 · External reference
Cardiovascular-kidney-metabolic syndrome modifies smoking-related risk for cardiovascular diseases: Findings from an observational cohort study in UK Biobank
10.1186/s12889-025-22865-3 · 2025 · External reference
Cardiovascular-kidney-metabolic syndrome: Association with adverse events after major noncardiac surgery
10.1213/ane.0000000000006975 · 2024 · External reference
Prevalence and mortality of cardiovascular-kidney-metabolic syndrome in China: A nationwide population-based study
10.1016/j.jacasi.2025.04.007 · 2025 · External reference
Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020
10.1001/jama.2024.6892 · 2024 · External reference
Triglyceride-glucose index as a marker in cardiovascular diseases: Landscape and limitations
10.1186/s12933-022-01511-x · 2022 · External reference
Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: A systematic review and meta-analysis
10.1186/s12933-022-01546-0 · 2022 · External reference
A novel index for diagnosis of type 2 diabetes mellitus: Cholesterol, high density lipoprotein, and glucose (CHG) index
10.1111/jdi.14343 · 2025 · External reference
Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: A cohort study
10.1186/s12933-025-02675-y · 2025 · External reference
Cumulative serum uric acid and its time course are associated with risk of myocardial infarction and all-cause mortality
10.1161/jaha.120.020180 · 2021 · External reference
Association of cumulative blood pressure with cognitive decline, dementia, and mortality
10.1016/j.jacc.2022.01.045 · 2022 · External reference
Association of trajectory of cardiovascular health score and incident cardiovascular disease
10.1001/jamanetworkopen.2019.4758 · 2019 · External reference
Life's Essential 8 and heart failure among patients with chronic kidney disease: The Kailuan Cohort Study
10.1093/eurjpc/zwad398 · 2024 · External reference
Longitudinal change in fasting blood glucose and myocardial infarction risk in a population without diabetes
10.2337/dc17-0610 · 2017 · External reference
A new equation to estimate glomerular filtration rate
10.7326/0003-4819-150-9-200905050-00006 · 2009 · External reference
The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects
10.1089/met.2008.0034 · 2008 · External reference
Association between cumulative atherogenic index of plasma exposure and risk of myocardial infarction in the general population
10.1186/s12933-023-01936-y · 2023 · External reference
Unresolved reference
2010 · External reference
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
10.1161/01.cir.90.1.583 · 1994 · External reference
Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders
10.1161/01.str.20.10.1407 · 1989 · External reference
Chinese guidelines for the diagnosis and treatment of heart failure 2018
10.3760/cma.j.issn.0253-3758.2018.10.004 · 2018 · External reference
Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
10.1093/eurheartj/ehq278 · 2010 · External reference
Longitudinal patterns of blood pressure, incident cardiovascular events, and all-cause mortality in normotensive diabetic people
10.1161/hypertensionaha.116.07381 · 2016 · External reference
Chinese guidelines for the prevention and treatment of hypertension (2024 revision)
10.26599/1671-5411.2025.01.008 · 2025 · External reference
Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: A scientific statement from the American Heart Association and the American Diabetes Association
10.2337/dci15-0012 · 2015 · External reference
Chinese guidelines for lipid management (2023)
10.3760/cma.j.cn112148-20230119-00038 · 2023 · External reference
Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline
10.7326/0003-4819-158-11-201306040-00007 · 2013 · External reference
Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: The China-PAR Project (Prediction for ASCVD Risk in China)
10.1161/circulationaha.116.022367 · 2016 · External reference
Evaluate Cutpoints: Adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator
10.1016/j.cmpb.2019.05.023 · 2019 · External reference
Time course of the triglyceride glucose index accumulation with the risk of cardiovascular disease and all-cause mortality
10.1186/s12933-022-01617-2 · 2022 · External reference
Cumulative triglyceride-glucose index is a risk for CVD: A prospective cohort study
10.1186/s12933-022-01456-1 · 2022 · External reference
Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: An analysis of UK Biobank data
10.1186/s12933-023-01762-2 · 2023 · External reference
Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0-3: A nationwide prospective cohort study
10.1186/s12933-025-02662-3 · 2025 · External reference
Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: A prospective cohort study of 282,920 participants in the UK Biobank
10.1186/s12933-025-02842-1 · 2025 · External reference
Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with cardiovascular-kidney-metabolic syndrome stage 0-3: A nationwide prospective cohort study
10.1186/s12933-024-02352-6 · 2024 · External reference
Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0-3: A nationwide prospective cohort study
10.1186/s12933-025-02754-0 · 2025 · External reference
Insulin resistance and bronze diabetes
10.1056/nejm192908012010501 · 1929 · External reference
Insulin resistance is a cardiovascular risk factor in humans
10.1016/j.jacbts.2018.04.003 · 2019 · External reference
Potentiation of insulin signaling contributes to heart failure in type 2 diabetes: A hypothesis supported by both mechanistic studies and clinical trials
10.1016/j.jacbts.2018.04.003 · 2018 · External reference
Glucose clamp technique: A method for quantifying insulin secretion and resistance
10.1152/ajpendo.1979.237.3.e214 · 1979 · External reference
Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
10.1007/bf00280883 · 1985 · External reference
Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension
10.1111/jch.14155 · 2021 · External reference
Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: A systematic review
10.1155/2020/4678526 · 2020 · External reference
Here's what to know about cardiovascular-kidney-metabolic syndrome, newly defined by the AHA
10.1001/jama.2023.22276 · 2023 · External reference
Adipose tissue dysfunction as determinant of obesity-associated metabolic complications
10.3390/ijms20092358 · 2019 · External reference
Insulin resistance, cardiovascular stiffening and cardiovascular disease
10.1016/j.metabol.2021.154766 · 2021 · External reference
The pancreatic β-cell in ageing: Implications in age-related diabetes
10.1016/j.arr.2022.101674 · 2022 · External reference
Aging and vascular endothelial function in humans
10.1042/cs20100476 · 2011 · External reference
Age-related impairment of vascular structure and functions
10.14336/ad.2017.0430 · 2017 · External reference
Arterial stiffness and vascular aging: mechanisms, prevention, and therapy
10.1038/s41392-025-02346-0 · 2025 · External reference
The implications of aging on vascular health
10.3390/ijms252011188 · 2024 · External reference
Trajectories of triglyceride-glucose index changes and their association with all-cause and cardiovascular mortality: a competing risk analysis
10.1186/s12933-024-02457-y · 2024 · External reference
Here's what to know about cardiovascular-kidney-metabolic syndrome, newly defined by the AHA
10.1001/jama.2023.22276 · ExternalCitation · doi-reference
Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020
10.1001/jama.2024.6892 · ExternalCitation · doi-reference
Association of trajectory of cardiovascular health score and incident cardiovascular disease
10.1001/jamanetworkopen.2019.4758 · ExternalCitation · doi-reference
Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
10.1007/bf00280883 · ExternalCitation · doi-reference
The pancreatic β-cell in ageing: Implications in age-related diabetes
10.1016/j.arr.2022.101674 · ExternalCitation · doi-reference
Evaluate Cutpoints: Adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator
10.1016/j.cmpb.2019.05.023 · ExternalCitation · doi-reference
Prevalence and mortality of cardiovascular-kidney-metabolic syndrome in China: A nationwide population-based study
10.1016/j.jacasi.2025.04.007 · ExternalCitation · doi-reference
Potentiation of insulin signaling contributes to heart failure in type 2 diabetes: A hypothesis supported by both mechanistic studies and clinical trials
10.1016/j.jacbts.2018.04.003 · ExternalCitation · doi-reference
Association of cumulative blood pressure with cognitive decline, dementia, and mortality
10.1016/j.jacc.2022.01.045 · ExternalCitation · doi-reference
Insulin resistance, cardiovascular stiffening and cardiovascular disease
10.1016/j.metabol.2021.154766 · ExternalCitation · doi-reference
Arterial stiffness and vascular aging: mechanisms, prevention, and therapy
10.1038/s41392-025-02346-0 · ExternalCitation · doi-reference
Aging and vascular endothelial function in humans
10.1042/cs20100476 · ExternalCitation · doi-reference
Insulin resistance and bronze diabetes
10.1056/nejm192908012010501 · ExternalCitation · doi-reference
The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects
10.1089/met.2008.0034 · ExternalCitation · doi-reference
Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
10.1093/eurheartj/ehq278 · ExternalCitation · doi-reference
Life's Essential 8 and heart failure among patients with chronic kidney disease: The Kailuan Cohort Study
10.1093/eurjpc/zwad398 · ExternalCitation · doi-reference
Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan
10.1111/dom.14829 · ExternalCitation · doi-reference
Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension
10.1111/jch.14155 · ExternalCitation · doi-reference
A novel index for diagnosis of type 2 diabetes mellitus: Cholesterol, high density lipoprotein, and glucose (CHG) index
10.1111/jdi.14343 · ExternalCitation · doi-reference
Glucose clamp technique: A method for quantifying insulin secretion and resistance
10.1152/ajpendo.1979.237.3.e214 · ExternalCitation · doi-reference
Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: A systematic review
10.1155/2020/4678526 · ExternalCitation · doi-reference
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
10.1161/01.cir.90.1.583 · ExternalCitation · doi-reference
Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders
10.1161/01.str.20.10.1407 · ExternalCitation · doi-reference
Cardiovascular-kidney-metabolic health: A presidential advisory from the American Heart Association
10.1161/cir.0000000000001184 · ExternalCitation · doi-reference
A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: A scientific statement from the American Heart Association
10.1161/cir.0000000000001186 · ExternalCitation · doi-reference
Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: The China-PAR Project (Prediction for ASCVD Risk in China)
10.1161/circulationaha.116.022367 · ExternalCitation · doi-reference
Longitudinal patterns of blood pressure, incident cardiovascular events, and all-cause mortality in normotensive diabetic people
10.1161/hypertensionaha.116.07381 · ExternalCitation · doi-reference
Cumulative serum uric acid and its time course are associated with risk of myocardial infarction and all-cause mortality
10.1161/jaha.120.020180 · ExternalCitation · doi-reference
Association of cardiovascular-kidney-metabolic syndrome with cognitive decline and dementia: The ARIC study insights
10.1161/jaha.124.038445 · ExternalCitation · doi-reference
Cardiovascular-kidney-metabolic syndrome modifies smoking-related risk for cardiovascular diseases: Findings from an observational cohort study in UK Biobank
10.1186/s12889-025-22865-3 · ExternalCitation · doi-reference
Cumulative triglyceride-glucose index is a risk for CVD: A prospective cohort study
10.1186/s12933-022-01456-1 · ExternalCitation · doi-reference
Triglyceride-glucose index as a marker in cardiovascular diseases: Landscape and limitations
10.1186/s12933-022-01511-x · ExternalCitation · doi-reference
Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: A systematic review and meta-analysis
10.1186/s12933-022-01546-0 · ExternalCitation · doi-reference
Time course of the triglyceride glucose index accumulation with the risk of cardiovascular disease and all-cause mortality
10.1186/s12933-022-01617-2 · ExternalCitation · doi-reference
Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: An analysis of UK Biobank data
10.1186/s12933-023-01762-2 · ExternalCitation · doi-reference
Association between cumulative atherogenic index of plasma exposure and risk of myocardial infarction in the general population
10.1186/s12933-023-01936-y · ExternalCitation · doi-reference
Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with cardiovascular-kidney-metabolic syndrome stage 0-3: A nationwide prospective cohort study
10.1186/s12933-024-02352-6 · ExternalCitation · doi-reference
Trajectories of triglyceride-glucose index changes and their association with all-cause and cardiovascular mortality: a competing risk analysis
10.1186/s12933-024-02457-y · ExternalCitation · doi-reference
Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0-3: A nationwide prospective cohort study
10.1186/s12933-025-02662-3 · ExternalCitation · doi-reference
Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: A cohort study
10.1186/s12933-025-02675-y · ExternalCitation · doi-reference
Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0-3: A nationwide prospective cohort study
10.1186/s12933-025-02754-0 · ExternalCitation · doi-reference
Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: A prospective cohort study of 282,920 participants in the UK Biobank
10.1186/s12933-025-02842-1 · ExternalCitation · doi-reference
Cardiovascular-kidney-metabolic syndrome: Association with adverse events after major noncardiac surgery
10.1213/ane.0000000000006975 · ExternalCitation · doi-reference
Age-related impairment of vascular structure and functions
10.14336/ad.2017.0430 · ExternalCitation · doi-reference
Longitudinal change in fasting blood glucose and myocardial infarction risk in a population without diabetes
10.2337/dc17-0610 · ExternalCitation · doi-reference
Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: A scientific statement from the American Heart Association and the American Diabetes Association
10.2337/dci15-0012 · ExternalCitation · doi-reference
Chinese guidelines for the prevention and treatment of hypertension (2024 revision)
10.26599/1671-5411.2025.01.008 · ExternalCitation · doi-reference
Adipose tissue dysfunction as determinant of obesity-associated metabolic complications
10.3390/ijms20092358 · ExternalCitation · doi-reference
The implications of aging on vascular health
10.3390/ijms252011188 · ExternalCitation · doi-reference
Chinese guidelines for lipid management (2023)
10.3760/cma.j.cn112148-20230119-00038 · ExternalCitation · doi-reference
Chinese guidelines for the diagnosis and treatment of heart failure 2018
10.3760/cma.j.issn.0253-3758.2018.10.004 · ExternalCitation · doi-reference
A new equation to estimate glomerular filtration rate
10.7326/0003-4819-150-9-200905050-00006 · ExternalCitation · doi-reference
Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline
10.7326/0003-4819-158-11-201306040-00007 · ExternalCitation · doi-reference
